During the past decade, Institute Of Cardiology conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute Of Cardiology" #1 sponsor was "National Institute of Cardiology, Warsaw, Poland" with 23 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Biotronik SE & Co. KG" with 2 trials sponsored and "Eidos Therapeutics, a BridgeBio company" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute Of Cardiology" #1 collaborator was "National Institute of Cardiology, Warsaw, Poland" with 3 trials as a collaborator, "ICON plc" with 2 trials as a collaborator, "Medical University of Bialystok" with 2 trials as a collaborator, "Ministry of Science and Higher Education, Poland" with 2 trials as a collaborator and "Amsterdam UMC, location VUmc" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Institute Of Cardiology" are "Coronary Artery Disease" (14 trials), "Hypertension" (6 trials), "Atrial Fibrillation" (4 trials), "Heart Failure" (4 trials) and "Myocardial Infarction" (4 trials). Many other conditions were trialed in "Institute Of Cardiology" in a lesser frequency.

Most popular intervention types in "Institute Of Cardiology" are "Device" (21 trials), "Procedure" (12 trials), "Drug" (8 trials), "Other" (7 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Prolonged telemetric Full Disclosure ECG recording." (3 trials), "Lucerastat" (2 trials), "Placebo" (2 trials), "XIENCE V®/ XIENCE PRIME™" (2 trials) and "ACE inhibitors and/or ARB and/or AA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute Of Cardiology" are 47 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 10 active trials in "Institute Of Cardiology". 2 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in Institute Of Cardiology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute Of Cardiology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 22 trials that are defined as “Not Applicable".